China health care companies received a significant reprieve in terms of geopolitical risks when the US Senate declined to ...

Whitehawk Therapeutics (Nasdaq: WHWK), formerly Aadi Bioscience, has officially rebranded to reflect its transformation into ...

Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its ...

With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the brighter side for 2025. | With the fate ...

WuXi has disputed an early WBJ report saying construction at the Worcester site has stopped, although the company declined to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The company was ranked top in its industry and received a Top 1% S&P Global Corporate Sustainability Assessment (CSA) Score, marking the third year WuXi Biologics has received this highest level ...

Trump threatened to enact 200% tariffs on all alcoholic products coming from the European Union in retaliation for the bloc’s ...

Hong Kong stocks rose on Friday, halting a five-day slump, as investors resumed buying tech companies on optimism advances in ...

Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, March 10, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been included in the S&P Global Sustainability ...